Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Bikash Medhi and Harpinder Kaur.
Bikash Medhi
Connection Strength
2.060
Harpinder Kaur
  1. Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes. Pharmacol Rep. 2021 Jun; 73(3):736-749.
    View in: PubMed
    Score: 0.922
  2. Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review. Phytother Res. 2021 Aug; 35(8):4456-4484.
    View in: PubMed
    Score: 0.238
  3. Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review. Tissue Cell. 2021 Jun; 70:101497.
    View in: PubMed
    Score: 0.232
  4. Novel therapeutic approaches toward Hantaan virus and its clinical features' similarity with COVID-19. Indian J Pharmacol. 2020 Sep-Oct; 52(5):347-355.
    View in: PubMed
    Score: 0.225
  5. Pattern of clinical research in the era of COVID-19 pandemic: A new learning experience for the present as well as future. Indian J Pharmacol. 2020 Jul-Aug; 52(4):249-253.
    View in: PubMed
    Score: 0.223
  6. COVID-19 pandemic: A review based on current evidence. Indian J Pharmacol. 2020 Mar-Apr; 52(2):117-129.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.